Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice

Lipeng Yang; Xingyuan Zhang; Songsong Fan; Xuefeng Cao

doi:doi:10.11648/j.ijg.20210502.14

| Peer-Reviewed

Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice

Lipeng Yang, Xingyuan Zhang, Songsong Fan, Xuefeng Cao

Published in International Journal of Gastroenterology (Volume 5, Issue 2)

Received: 7 August 2021 Accepted: 17 August 2021 Published: 31 August 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (¹²⁵ I) seed strand implantation, biliary radiofrequency ablation（RFA）and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.

Published in	International Journal of Gastroenterology (Volume 5, Issue 2)
DOI	10.11648/j.ijg.20210502.14
Page(s)	57-61
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

MOJ, Interventional Therapy, Bile Duct Interventional Drainage, Biliary Stenting

References

[1]	Rungsakulkij N, Sornmayura P, Tannaphai P. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report. BMC Surg. 2017 Feb 15; 17 (1): 17. doi: 10.1186/s12893-017-0214-1. PMID: 28202062; PMCID: PMC5311850.
[2]	Duan F, Cui L, Bai Y, Li X, Yan J, Liu X. Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis. Cancer Imaging. 2017 Oct 16; 17 (1): 27. doi: 10.1186/s40644-017-0129-1. PMID: 29037223; PMCID: PMC5644169.
[3]	Al Mahjoub A, Menahem B, Fohlen A, Dupont B, Alves A, Launoy G, Lubrano J. Preoperative Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: Is Percutaneous Transhepatic Biliary Drainage Safer and More Effective than Endoscopic Biliary Drainage? A Meta-Analysis. J Vasc Interv Radiol. 2017 Apr; 28 (4): 576-582. doi: 10.1016/j.jvir.2016.12.1218. PMID: 28343588.
[4]	Chandrashekhara SH, Gamanagatti S, Singh A, Bhatnagar S. Current Status of Percutaneous Transhepatic Biliary Drainage in Palliation of Malignant Obstructive Jaundice: A Review. Indian J Palliat Care. 2016 Oct-Dec; 22 (4): 378-387. doi: 10.4103/0973-1075.191746. PMID: 27803558; PMCID: PMC5072228.
[5]	Varadarajulu S. Endoscopic Ultrasound-Guided Biliary Drainage for Palliation of Malignant Obstructive Jaundice. Gastroenterol Hepatol (N Y). 2019 Feb; 15 (2): 105-107. PMID: 31011304; PMCID: PMC6469261.
[6]	Dumonceau JM, Tringali A, Papanikolaou IS, Blero D, Mangiavillano B, Schmidt A, Vanbiervliet G, Costamagna G, Devière J, García-Cano J, Gyökeres T, Hassan C, Prat F, Siersema PD, van Hooft JE. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy. 2018 Sep; 50 (9): 910-930. doi: 10.1055/a-0659-9864. Epub 2018 Aug 7. PMID: 30086596.
[7]	Gamanagatti S, Singh T, Sharma R, Srivastava DN, Dash NR, Garg PK. Unilobar Versus Bilobar Biliary Drainage: Effect on Quality of Life and Bilirubin Level Reduction. Indian J Palliat Care. 2016 Jan-Mar; 22 (1): 50-62. doi: 10.4103/0973-1075.173958. PMID: 26962281; PMCID: PMC4768450.
[8]	Zhang X, Wang X, Wang L, Tang R, Dong J. Effect of covered self-expanding metal stents compared with multiple plastic stents on benign biliary stricture: A meta-analysis. Medicine (Baltimore). 2018 Sep; 97 (36): e12039. doi: 10.1097/MD.0000000000012039. PMID: 30200083; PMCID: PMC6133465.
[9]	Dumonceau JM, Tringali A, Blero D, Devière J, Laugiers R, Heresbach D, Costamagna G; European Society of Gastrointestinal Endoscopy. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012 Mar; 44 (3): 277-98. doi: 10.1055/s-0031-1291633. Epub 2012 Feb 1. PMID: 22297801.
[10]	Ciambella CC, Beard RE, Miner TJ. Current role of palliative interventions in advanced pancreatic cancer. World J Gastrointest Surg. 2018 Oct 27; 10 (7): 75-83. doi: 10.4240/wjgs.v10.i7.75. PMID: 30397425; PMCID: PMC6212542.
[11]	Petrone MC, Archibugi L, Forti E, Conigliaro R, Di Mitri R, Tarantino I, Fabbri C, Larghi A, Testoni SGG, Mutignani M, Arcidiacono PG. Novel lumen-apposing metal stent for the drainage of pancreatic fluid collections: An Italian multicentre experience. United European Gastroenterol J. 2018 Nov; 6 (9): 1363-1371. doi: 10.1177/2050640618785078. Epub 2018 Jun 17. PMID: 30386609; PMCID: PMC6206530.
[12]	Li S, He X, Dang L, Xu F, Fang J, Li F, Wang W. Efficacy of 125I Versus Non-125I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice. Dig Dis Sci. 2018 Feb; 63 (2): 321-328. doi: 10.1007/s10620-017-4899-x. Epub 2018 Jan 5. PMID: 29305738.
[13]	Wang HW, Li XJ, Li SJ, Lu JR, He DF. Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice. World J Clin Cases. 2021 Feb 6; 9 (4): 801-811. doi: 10.12998/wjcc.v9.i4.801. PMID: 33585626; PMCID: PMC7852634.
[14]	Zhu HD, Guo JH, Zhu GY, He SC, Fang W, Deng G, Qin YL, Li GZ, Coldwell DM, Teng GJ. A novel biliary stent loaded with (125) I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol. 2012 May; 56 (5): 1104-1111. doi: 10.1016/j.jhep.2011.12.018. Epub 2012 Jan 17. PMID: 22266605.
[15]	Xia N, Gong J, Lu J, Chen ZJ, Zhang LY, Wang ZM. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result. World J Gastroenterol. 2017 Mar 14; 23 (10): 1851-1856. doi: 10.3748/wjg.v23.i10.1851. PMID: 28348491; PMCID: PMC5352926.
[16]	Monga A, Gupta R, Ramchandani M, Rao GV, Santosh D, Reddy DN. Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality (with videos). Gastrointest Endosc. 2011 Oct; 74 (4): 935-7. doi: 10.1016/j.gie.2010.10.018. Epub 2010 Dec 18. PMID: 21168839.
[17]	Khorsandi SE, Zacharoulis D, Vavra P, Navarra G, Kysela P, Habib N. The modern use of radiofrequency energy in surgery, endoscopy and interventional radiology. Eur Surg. 2008; 40: 204–210.
[18]	Jain S, Kataria T, Bisht SS, Gupta D, Vikraman S, Baijal S, Sud R. Malignant obstructive jaundice - brachytherapy as a tool for palliation. J Contemp Brachytherapy. 2013 Jun; 5 (2): 83-8. doi: 10.5114/jcb.2013.35563. Epub 2013 Jun 28. PMID: 23878552; PMCID: PMC3708146.

Cite This Article

Plain Text BibTeX RIS

APA Style

Lipeng Yang, Xingyuan Zhang, Songsong Fan, Xuefeng Cao. (2021). Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice. International Journal of Gastroenterology, 5(2), 57-61. https://doi.org/10.11648/j.ijg.20210502.14

Copy | Download

ACS Style

Lipeng Yang; Xingyuan Zhang; Songsong Fan; Xuefeng Cao. Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice. Int. J. Gastroenterol. 2021, 5(2), 57-61. doi: 10.11648/j.ijg.20210502.14

Copy | Download

AMA Style

Lipeng Yang, Xingyuan Zhang, Songsong Fan, Xuefeng Cao. Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice. Int J Gastroenterol. 2021;5(2):57-61. doi: 10.11648/j.ijg.20210502.14

Copy | Download

@article{10.11648/j.ijg.20210502.14,
  author = {Lipeng Yang and Xingyuan Zhang and Songsong Fan and Xuefeng Cao},
  title = {Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice},
  journal = {International Journal of Gastroenterology},
  volume = {5},
  number = {2},
  pages = {57-61},
  doi = {10.11648/j.ijg.20210502.14},
  url = {https://doi.org/10.11648/j.ijg.20210502.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijg.20210502.14},
  abstract = {Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (125 I) seed strand implantation, biliary radiofrequency ablation（RFA）and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice
AU  - Lipeng Yang
AU  - Xingyuan Zhang
AU  - Songsong Fan
AU  - Xuefeng Cao
Y1  - 2021/08/31
PY  - 2021
N1  - https://doi.org/10.11648/j.ijg.20210502.14
DO  - 10.11648/j.ijg.20210502.14
T2  - International Journal of Gastroenterology
JF  - International Journal of Gastroenterology
JO  - International Journal of Gastroenterology
SP  - 57
EP  - 61
PB  - Science Publishing Group
SN  - 2640-169X
UR  - https://doi.org/10.11648/j.ijg.20210502.14
AB  - Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (125 I) seed strand implantation, biliary radiofrequency ablation（RFA）and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.
VL  - 5
IS  - 2
ER  -

Copy | Download

Author Information

Lipeng Yang

Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, China
Xingyuan Zhang

Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, China
Songsong Fan

Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, China
Xuefeng Cao

Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Lipeng Yang, Xingyuan Zhang, Songsong Fan, Xuefeng Cao. (2021). Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice. International Journal of Gastroenterology, 5(2), 57-61. https://doi.org/10.11648/j.ijg.20210502.14

Copy | Download

ACS Style

Lipeng Yang; Xingyuan Zhang; Songsong Fan; Xuefeng Cao. Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice. Int. J. Gastroenterol. 2021, 5(2), 57-61. doi: 10.11648/j.ijg.20210502.14

Copy | Download

AMA Style

Lipeng Yang, Xingyuan Zhang, Songsong Fan, Xuefeng Cao. Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice. Int J Gastroenterol. 2021;5(2):57-61. doi: 10.11648/j.ijg.20210502.14

Copy | Download

@article{10.11648/j.ijg.20210502.14,
  author = {Lipeng Yang and Xingyuan Zhang and Songsong Fan and Xuefeng Cao},
  title = {Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice},
  journal = {International Journal of Gastroenterology},
  volume = {5},
  number = {2},
  pages = {57-61},
  doi = {10.11648/j.ijg.20210502.14},
  url = {https://doi.org/10.11648/j.ijg.20210502.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijg.20210502.14},
  abstract = {Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (125 I) seed strand implantation, biliary radiofrequency ablation（RFA）and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice
AU  - Lipeng Yang
AU  - Xingyuan Zhang
AU  - Songsong Fan
AU  - Xuefeng Cao
Y1  - 2021/08/31
PY  - 2021
N1  - https://doi.org/10.11648/j.ijg.20210502.14
DO  - 10.11648/j.ijg.20210502.14
T2  - International Journal of Gastroenterology
JF  - International Journal of Gastroenterology
JO  - International Journal of Gastroenterology
SP  - 57
EP  - 61
PB  - Science Publishing Group
SN  - 2640-169X
UR  - https://doi.org/10.11648/j.ijg.20210502.14
AB  - Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (125 I) seed strand implantation, biliary radiofrequency ablation（RFA）and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.
VL  - 5
IS  - 2
ER  -

Copy | Download